Fact-checked by Grok 2 weeks ago

Bladder exstrophy


Bladder exstrophy is a congenital in which the urinary fails to close properly during fetal , resulting in the bladder mucosa protruding through a defect in the lower anterior . This condition, the most severe manifestation of the bladder exstrophy- complex, is characterized by an open with continuous exposure to air, accompanied by defects in the pubic bones, genitalia (such as ), and musculature. It occurs in approximately 2.15 per 100,000 live births, with a marked predominance (-to-female of about 2:1 to 6:1).
The of exstrophy remains incompletely understood but involves disruptions in the cloacal membrane during early embryogenesis, potentially influenced by genetic and environmental factors, though no single causative agent has been identified. At birth, infants present with an eviscerated , separated pubic rami, and often umbilical anomalies, leading to immediate risks of , , and if untreated. is typically evident at delivery but can be suspected prenatally via findings such as absent bladder filling or spinal anomalies. Management requires multidisciplinary surgical intervention, beginning with primary closure of the abdominal wall and bladder within days of birth to preserve renal function and facilitate future reconstructions. Subsequent staged procedures address bladder capacity augmentation, urethral reconstruction, and genital correction, with long-term goals of achieving urinary continence (successful in 60-80% of cases with modern techniques), sexual function, and fertility preservation. Despite advances, challenges persist, including risks of renal deterioration, orthopedic issues from pelvic deformity, and psychosocial impacts, necessitating lifelong follow-up.

Definition and Classification

Exstrophy-Epispadias Complex Spectrum

The exstrophy-epispadias complex (EEC), also termed bladder exstrophy-epispadias complex (BEEC), comprises a spectrum of congenital midline malformations primarily affecting the lower urinary and genital tracts, anterior , and bony . These defects arise from abnormal embryological development during the fourth to sixth weeks of , involving failure of the cloacal membrane to properly regress and ventral body wall closure. The spectrum is characterized by varying degrees of exstrophy, defined as the eversion or exposure of internal organs through an abdominal wall defect, with severity correlating to the extent of infraumbilical midline fusion failure. At the mild end of the spectrum lies , featuring a urethral opening proximal to the in males or above the in females, often accompanied by due to inadequate urethral mechanism and . Classical bladder exstrophy (CBE), the intermediate form occurring in approximately 1 in 30,000 to 50,000 live births, presents with an open, everted bladder mucosa exposed via a lower defect, short wide , , bifid or penile anomalies, and separated pubic rami. CBE is frequently associated with in nearly all cases and in about 20-30% of patients. The severe end includes (CE), also known as OEIS complex (, exstrophy, , spinal defects), marked by two exstrophied halves flanking an exposed caecum with prolapsed , complete urethral absence, genital ambiguity, and spinal dysraphism in up to 50% of cases. Incidence of CE is rarer, estimated at 1 in 200,000 to 400,000 live births. Variant forms within the EEC spectrum, such as superior vesical fissure (a partial exstrophy with intact dome and small suprapubic defect) and covered or duplicate exstrophy, represent hybrid or atypical presentations that bridge classical entities but share core features of pelvic bone separation and genitourinary dysmorphology. These variants occur in less than 10% of EEC cases and often require tailored diagnostic imaging for differentiation. Classification of EEC relies on anatomical extent and associated anomalies, with classified as distal, penile, or penopubic based on urethral defect location, while exstrophy forms are delineated by organ involvement—urogenital alone in CBE versus combined urogenital-gastrointestinal in . Prenatal via may detect signs like absent filling, spinal defects, or lower abdominal mass as early as 13-16 weeks , though postnatal confirmation remains standard. Genetic factors contribute in familial clusters, with monozygotic twin concordance up to 8% versus 1.5% in dizygotic, but most cases are sporadic without identified mutations.

Variants of Bladder Exstrophy

Pseudoexstrophy features an intact covering over the without mucosal or urinary leakage, accompanied by pubic diastasis and divergent rectus abdominis muscles similar to classical bladder exstrophy, but with normal function and no need for . The may bulge externally when distended, and genital anomalies such as can occur, though continence is typically preserved. Superior vesical fissure involves a small defect at the superodorsal neck, resulting in partial exstrophy without the full separation or lower urinary tract involvement seen in classical forms; the remainder of the remains closed, often presenting with prolapsed mucosa near the umbilicus. Pelvic abnormalities are usually absent, distinguishing it from more severe variants. Duplicate exstrophy consists of a normal functional alongside an accessory exstrophic bladder plate, which appears as a flat, non-functional mucosal segment on the ; pelvic bones may exhibit diastasis akin to classical exstrophy, and the duplicate plate typically produces no urine. This rare form accounts for a small fraction of cases within the exstrophy-epispadias complex. Covered exstrophy presents with a skin-covered or bowel segment exposed on the , pubic diastasis, and often exstrophied or , but without continuous leakage from an open bladder plate. Visible reddish mucosa beneath cover and orthotopic umbilicus are common, with variable genital and musculoskeletal defects. These variants collectively comprise approximately 10% of bladder exstrophy cases within the broader exstrophy-epispadias spectrum, arising from partial failures in and closure during embryogenesis. Diagnosis relies on prenatal or postnatal to differentiate from classical bladder exstrophy, influencing surgical timing and approach.

and

Genetic and Environmental Factors

Bladder exstrophy-epispadias complex (BEEC), which includes bladder exstrophy, exhibits a multifactorial involving both genetic and environmental influences, with most cases being sporadic rather than following strict Mendelian patterns. Twin studies demonstrate higher concordance rates in monozygotic twins (62%) compared to dizygotic twins (11%), supporting a substantial genetic component. Recurrence risks are elevated in families, estimated at 0.3-2.3% for siblings and 1.4% for offspring of affected individuals, representing a 400-fold increase over the general incidence. Rare familial cases suggest possible autosomal dominant inheritance with reduced or autosomal recessive patterns, though the majority align with polygenic risk modulated by environmental triggers. Genome-wide association studies (GWAS) and whole-exome sequencing have identified candidate genes such as ISL1 (strongly associated with classic bladder exstrophy, p = 9.2 × 10⁻¹⁹), WNT3, SLC20A1, , and AP2, with supporting evidence from animal models where disruptions lead to analogous urogenital defects. Copy number variants (CNVs) also contribute, including 22q11.21 duplications that confer a 12- to 30-fold increased and other deletions or duplications (e.g., on chromosomes 1q, 19p) implicated in pelvic and urinary tract malformations. These findings indicate a complex genomic architecture, but no single variant accounts for most cases, underscoring the polygenic nature and need for larger cohort studies to pinpoint causal loci. Environmental exposures during early modify BEEC , with maternal and first-trimester linked to higher incidence of severe forms, potentially through disruption of cloacal integrity. Periconceptional supplementation appears protective against severe manifestations, possibly by supporting mesenchymal migration essential for closure. Valproic exposure in elevates , as do certain chemicals and pollutants, though definitive causal links remain under investigation via case-control studies. (>35 years) and further correlate with increased odds, highlighting interactions between modifiable factors and underlying genetic susceptibility. No single environmental agent has been conclusively identified as a primary cause, consistent with the disorder's multifactorial framework.

Embryological Mechanisms

Bladder exstrophy arises from disruptions in the normal embryological closure of the ventral and cloacal region during the fourth to sixth weeks of . In typical development, the cloacal membrane, composed of and without intervening , forms the ventral aspect of the caudal by the third week. By the fourth week, rapid caudal elongation and ventral curvature position the cloacal membrane as the future , with paired primordia emerging cranially. Mesenchymal tissue migrates medial to the primordia, facilitating midline fusion and formation, while the divides the into and anorectal components by the seventh week, establishing the from the ventral sinus. The precise embryopathogenesis remains unclear, with classical bladder exstrophy occurring sporadically without a proven monogenic basis or consistent environmental trigger, challenging purely embryological defect models. The predominant hypothesis, proposed by and Muecke, posits an enlarged or persistent cloacal membrane that inhibits mesenchymal ingrowth, weakening the lower and leading to membrane rupture, eversion of the plate, and failure of infraumbilical midline fusion. This results in exstrophy of the mucosa, (averaging 4 cm at birth), and associated defects in the , genitalia, and pelvic bones. Experimental animal models support early membrane rupture as a contributor, though human evidence is indirect. Alternative mechanisms emphasize upstream derangements in midline developmental fields. One suggests abnormal persistence of the body stalk's caudal insertion, delaying ventral body wall closure and causing secondary cloacal membrane stress. Another implicates a cephalad of primordia, creating a that blocks medial migration and midline approximation, evidenced by anatomical measurements in exstrophy cases showing equivalent distances from inguinal crease to displaced genitalia compared to controls. These models highlight a spectrum within the exstrophy-epispadias complex, where milder reflects partial fusion failure and severe involves complete urorectal septum defects. Pubic diastasis may precede or exacerbate soft tissue anomalies, with pelvic segments externally rotated and anterior segments shortened by 30% in affected individuals. Despite these proposals, no single theory fully accounts for the condition's rarity (1 in 30,000-50,000 live births) and lack of familial recurrence beyond 1-5%.

Epidemiology

Incidence and Prevalence

Bladder exstrophy, particularly the classical form, has a birth of approximately 3.3 per 100,000 live births, with estimates ranging from 2 to 4 per 100,000 across studies. This equates to roughly 1 in 30,000 to 50,000 live births globally, though rates vary by region and registry methodology. , a nationwide analysis identified an incidence of 2.15 per 100,000 live births based on hospital discharge data from over 9 million newborns. Multicountry surveillance data from birth defect registries report a pooled prevalence of 2.58 per 100,000 births for bladder exstrophy, with a noted decline over time from 2000 to 2014 potentially attributable to improved prenatal detection and selective terminations. European registries, such as EUROCAT, estimate 4.3 per 100,000 live births when including associated epispadias cases within the exstrophy-epispadias complex. These figures underscore the rarity of the condition, with total prevalence for isolated cases in some cohorts reaching 3.52 per 100,000 births. Prevalence estimates derive primarily from population-based birth defect surveillance systems and hospital registries, which may undercount due to underreporting or diagnostic challenges in low-resource settings. Recent analyses confirm stability in core incidence rates, with no significant temporal trends beyond diagnostic improvements.

Demographic Patterns

Bladder exstrophy demonstrates a consistent male predominance across most global studies, with male-to-female ratios typically ranging from 2:1 to 5:1 for classic cases, reflecting potential sex-linked embryological vulnerabilities in male genital development. A large-scale analysis of U.S. hospital data from 1988 to 2002, however, reported a near-even distribution (odds ratio 0.989, 95% CI 0.88-1.12), suggesting possible regional diagnostic or reporting influences that may undercount female cases elsewhere. Racial and ethnic patterns indicate higher incidence among individuals of European descent, with nonwhite populations in the U.S. showing significantly lower rates (adjusted 0.68 for nonwhites), potentially due to genetic factors or underascertainment in diverse groups. Prevalence appears lower in Latin American and African populations compared to Europeans (1 in 46,000 births in versus rarer reports elsewhere), though geographic variations are often attributed to differences in case registration and healthcare access rather than true etiological disparities. Familial recurrence is rare but elevated compared to the general , with an estimated of approximately 1% in siblings or offspring of affected individuals, and slightly higher genetic suggested in female probands due to potential multifactorial inheritance. Socioeconomic factors, such as uninsured status or extreme high/low socioeconomic strata, correlate with reduced reported incidence in U.S. data, likely reflecting barriers to rather than causal protection.

Clinical Presentation

Neonatal Signs

Bladder exstrophy in neonates presents as an open, everted plate exposed through a defect in the lower anterior , typically appearing as a red, fleshy mass in the suprapubic region with continuous leakage of . The exposed mucosa resembles raw beef, and the ureteral orifices may be visible on the surface, facilitating immediate recognition at birth. This defect results from failed closure of the infraumbilical , often accompanied by a low-set umbilicus and diastasis of the rectus abdominis muscles. Pubic separation, measuring approximately 4 cm at birth, contributes to the characteristic outward rotation of the hips. In male neonates, genital abnormalities include , characterized by a dorsal urethral opening along a short, broad with upward curvature ( ) and a flattened . The appears stubby and rotated outward, with widely splayed corpora cavernosa and a low-set, possibly empty due to undescended testes or associated inguinal hernias. Female neonates exhibit a bifid with separated halves, short , and anteriorly displaced vaginal orifice, sometimes with labial separation and potential vaginal duplication. in females manifests as an open urethral groove between the clitoral halves. Additional neonatal features include an anteriorly ectopic with a patulous prone to mucosal , reflecting defects. The infant's inability to retain urine leads to perpetual wetness, and while is common, it may not produce overt symptoms immediately postnatally. The condition is usually apparent on visual inspection without need for probing, which is contraindicated to avoid mucosal damage.

Associated Anomalies

Bladder exstrophy, as part of the exstrophy-epispadias complex, is associated with multiple congenital anomalies primarily affecting the musculoskeletal, genitourinary, and structures, with less frequent involvement of other systems. These defects arise from failed midline during embryogenesis, leading to characteristic deformities beyond the exposed itself. Musculoskeletal anomalies include separation of the measuring approximately 4 cm at birth, which progresses to about 8 cm by age 10 years, compared to a normal gap of less than 1 cm. The adopts an "open-book" configuration, with outward rotation of the anterior segments by around 18° and posterior segments by 12°, alongside shortening of the pubic rami by roughly 30%. Spinal anomalies, such as dysraphism, occur in about 7% of cases. Genitourinary anomalies encompass , which is invariably present, along with in nearly 100% of cases. In males, the is short, broad, and dorsally curved (), with a flattened , divergent corpora cavernosa, and frequently undescended testes; bilateral inguinal hernias develop in a subset of patients. Females exhibit a bifid , short , anteriorly displaced vaginal orifice, and occasional uterine or vaginal duplications. Upper urinary tract malformations, including ectopic kidneys or megaureters, affect approximately 33% of individuals. Gastrointestinal and pelvic floor anomalies may involve an anteriorly ectopic due to muscle defects, as well as a patulous anal sphincter with risk of mucosal . Unlike variants, classic bladder exstrophy rarely features or . Extragenitourinary anomalies beyond the spine are uncommon in isolated classic bladder exstrophy, distinguishing it from more severe complex variants, though comprehensive evaluation is essential to identify occult defects.

Diagnosis

Prenatal Detection

Prenatal detection of bladder exstrophy relies primarily on fetal ultrasonography, typically during the second-trimester anatomy scan around 20 weeks' gestation. Characteristic ultrasound findings include failure to visualize a normal filling and emptying bladder, a solid or heterogeneous mass protruding from the lower anterior abdominal wall, a low-set umbilicus with the umbilical cord insertion displaced inferiorly, and ambiguous or small external genitalia, particularly in male fetuses. Normal amniotic fluid volume is usually preserved, distinguishing it from obstructive uropathies. Diagnostic accuracy of ultrasound varies across studies, with sensitivities reported between 55% and 65% for classic bladder exstrophy, often limited by operator experience, fetal position, and subtle or evolving features in early gestation. Earlier detection as early as 14 weeks has been described, though most cases are identified between 14 and 36 weeks (mean 23 weeks). In population-based registries, prenatal identification remains low, with only about 10% of cases detected via routine ultrasound, frequently due to misinterpretation of the abdominal mass or overlooked bladder absence. Fetal (MRI) serves as an adjunctive tool to confirm suspicious findings, offering superior soft-tissue contrast to delineate the exstrophic plate, infraumbilical mass without a distinct lumen, and associated musculoskeletal defects such as pubic diastasis. MRI achieves higher diagnostic sensitivity, up to 94.7% in some series for related exstrophy variants, and is particularly useful when is inconclusive due to or posterior bowel loops mimicking the defect. However, routine MRI use is not universal, reserved for high-risk or ambiguous cases at specialized fetal imaging centers. Challenges in prenatal diagnosis include differentiation from mimics such as , persistent cloaca, or , where additional features like bowel evisceration or spinal anomalies may aid distinction. Accurate prenatal identification enables multidisciplinary counseling on surgical timing, delivery planning (often cesarean to protect the exposed mucosa), and potential associations with other anomalies, though postnatal confirmation remains essential given diagnostic limitations.

Postnatal Confirmation

The of bladder exstrophy is typically established clinically immediately after birth through , revealing characteristic external features such as an exposed, everted bladder mucosa appearing as a bright red, beefy mass at the midline lower abdomen, continuously dribbling urine due to the absence of a functional . In males, concomitant manifests as a short, dorsally rotated with an open urethral plate, while in females, the is often bifid with separated ; associated skeletal anomalies include pubic diastasis, outward rotation of the innominate bones, and a low-set umbilicus. These signs are , allowing provisional confirmation without delay, though multidisciplinary evaluation is initiated promptly to assess for comorbidities like spinal dysraphism or renal anomalies. To delineate the full anatomic extent and screen for associated defects, postnatal imaging is employed. Renal and bladder ultrasonography evaluates upper urinary tract integrity, identifying or in up to 50% of cases at presentation. (VCUG) confirms urethral patency and reflux, while spinal radiography or ultrasound detects tethered cord syndrome, present in 10-15% of patients. In ambiguous presentations, such as or covered exstrophy, MRI may provide detailed soft tissue visualization of defects or hemivertebrae, though it is not routine for classic cases where clinical findings suffice. and chromosomal analysis are considered if syndromic features suggest broader involvement, such as in OEIS complex. Early confirmation facilitates timely referral to specialized centers for staged reconstruction, as delays beyond 72 hours postnatally increase surgical complexity.

Treatment Approaches

Surgical Reconstruction

Surgical reconstruction constitutes the primary treatment for classic bladder exstrophy, with the objectives of closing the exposed bladder, approximating the pelvic ring, achieving urinary continence via voiding, preserving renal function, and supporting sexual and reproductive potential. The predominant approach is the modern staged repair of exstrophy (MSRE), which sequences procedures to optimize tissue growth and minimize complications, though complete primary repair of exstrophy () represents an alternative single-stage . Success hinges on meticulous primary , as dehiscence or in the initial stage elevates risks of , reduced bladder capacity, and subsequent failure rates exceeding 50% without reintervention. In MSRE, the first stage focuses on neonatal and closure, ideally within 48-72 hours of birth to leverage pelvic malleability, though delays to 6-12 weeks may reduce risks in preterm infants. Surgical steps include a circumferential incision around the bladder plate, to mobilize the hemibladders and ureters, approximation of the posterior bladder wall over an 8-10 French catheter using fine absorbable sutures (e.g., 5-0 or 6-0 PDS) in a watertight, tension-free manner, and midline abdominal closure. Pelvic osteotomies—such as bilateral posterior iliac, transverse innominate, or combined types—are incorporated for diastasis exceeding 4 cm, infants over 72 hours old, or rigid pelvic bones to enable approximation and deeper bladder positioning, reducing dehiscence from 40% to under 10%. Postoperative employs modified Buck's or Bryant's traction, spica casting, or for 4-6 weeks, alongside antibiotics and anticholinergics to prevent infection and promote bladder cycling. The second stage addresses at 6-12 months, reconstructing the via techniques like the modified Cantwell-Ransley (tubularizing the dorsal urethral strip with glansplasty) or Mitchell penile disassembly to correct and improve , while deferring full continence procedures to allow bladder maturation. The third stage, performed at 4-5 years once bladder capacity reaches 60-100 mL under , entails bladder neck reconstruction—such as Young-Dees-Leadbetter plasty involving posterior urethral lengthening and trigonal advancement—often with bilateral ureteral reimplantation (e.g., technique) to mitigate , which affects up to 90% of cases preoperatively. Adjunctive measures may include bladder neck tunneled augmentation or sling if initial capacity is inadequate. CPRE integrates bladder closure, epispadias repair, and preliminary bladder neck reconstruction (with optional ureteral reimplantation) in one neonatal operation to potentially streamline care and enhance early continence. However, empirical data indicate continence rates of only 48% without further , with elevated risks of , , and need for secondary bladder neck reconstruction in over 50% of patients, prompting preference for MSRE in many centers where up to 70% achieve dry daytime continence post-staging. Osteotomies remain integral in both paradigms for older neonates, though their routine use lacks universal consensus due to comparable long-term pelvic alignment without them in primary closures. All reconstructions demand multidisciplinary input, including , orthopedics, and , with catheterization protocols post- to safeguard upper tracts.

Supportive and Multidisciplinary Care

Management of bladder exstrophy requires a coordinated multidisciplinary comprising neonatologists, pediatric urologists, orthopedic surgeons, anesthesiologists, , psychologists, nutritionists, and social workers to address the complex anatomical, functional, and psychosocial needs from infancy through adulthood. This approach facilitates primary closure, subsequent reconstructions, and ongoing monitoring, with staff serving as frontline providers for device , assessment, and creating a low-stress environment through clustered care and distraction techniques. Perioperative supportive care emphasizes post-closure—typically four weeks with pelvic osteotomies—to promote and reduce dehiscence risk, often involving Buck's traction for pelvic in older infants. Pain control relies on epidural analgesia with agents like lidocaine at 0.8 mg/kg/hour in neonates, alongside prophylaxis to prevent infections and nutritional support via nasogastric tubes if oral intake is limited. Orthopedic interventions, such as bilateral innominate or posterior iliac osteotomies, are integrated to close the pubic diastasis (typically 4-6 cm at birth), enabling tension-free urologic repair and improving long-term pelvic stability. Psychosocial support is integral, given the chronic nature of care and potential for issues, with integrated counseling addressing patient anxiety, family stress, and adjustment during prolonged hospitalizations. Early interventions include child life specialists for emotional and parental education on clean intermittent catheterization (), which supports continence in 70-80% of cases long-term but requires family commitment to and scheduling. Studies indicate that without such support, adolescents face heightened risks of challenges, underscoring the need for routine psychological evaluations within multidisciplinary clinics. Long-term follow-up in specialized centers involves serial assessments of renal function via ultrasounds and urodynamics, behavioral modifications, anticholinergics for detrusor overactivity, and to optimize mobility and continence. Multidisciplinary outpatient clinics coordinate these elements, with data from high-volume programs showing improved outcomes like reduced (53% incidence post-repair) through proactive input and on voiding programs.

Gender Identity Considerations

Biological Basis and Assignment Decisions

Bladder exstrophy arises from aberrant embryogenesis of the cloacal region during the fourth to sixth weeks of , when the cloacal membrane persists excessively and impedes mesenchymal tissue ingrowth, preventing proper ventral body wall closure. This results in an open plate, (typically 4-5 cm at birth), and anterior displacement of urogenital structures, with the incidence estimated at 1 in 30,000 to 50,000 live births, showing a male predominance of 2:1 to 6:1. The condition forms part of the exstrophy-epispadias complex, where rupture timing of the cloacal membrane influences severity: earlier disruptions yield more profound defects, as supported by animal models demonstrating failed cloacal partitioning. Etiologically multifactorial, bladder exstrophy involves genetic susceptibility without identified monogenic causes; sibling recurrence risks approximate 1%, while offspring of affected individuals face a 400-fold elevated risk, indicating heritability with incomplete penetrance. Environmental contributors, such as maternal exposure to or prostaglandins like , correlate with increased occurrence, though causation remains unestablished. Karyotypic evaluations in most cases confirm euploidy (46,XX or 46,XY), with sporadic chromosomal variants (e.g., trisomies or translocations) deemed incidental rather than etiologic. Gonadal differentiation proceeds normally, yielding functional testes in 46,XY fetuses or ovaries in 46,XX, unaffected by the ventral defects. Sex assignment decisions prioritize chromosomal constitution and gonadal status over external morphology, which, while deformed, aligns with biological sex: 46,XY males exhibit testes and a shortened, dorsally rotated with , precluding routine reassignment; 46,XX females display ovaries alongside bifid and short . Multidisciplinary evaluation, including karyotyping and hormonal assays, confirms this congruence, contrasting with where 46,XY historically prompted female reassignment—now largely abandoned in favor of male preservation due to evidence of androgen-driven male identity. In classic bladder exstrophy, surgical preserves natal sex, as longitudinal data affirm concordance with biological determinants, notwithstanding potential psychosocial strains from genital appearance.

Outcomes of Reassignment Protocols

In cases of bladder exstrophy where initial sex assignment was altered to in 46,XY individuals due to severe penile inadequacy, long-term outcomes have frequently shown discordance with the assigned sex. A study of 16 genetic s with (a severe variant often involving bladder exstrophy elements) raised as s after neonatal reassignment found that 14 eventually identified as , with 8 spontaneously declaring identity by ages 7 to 16, 5 living as s, and 2 in transition to ; only 2 maintained identity into adulthood. This pattern underscores the influence of prenatal exposure on , as reassigned individuals exhibited male-typical behaviors and attractions despite early gonadectomy and female rearing. Psychosocial and psychosexual outcomes in reassigned patients have been mixed but often suboptimal. Among children with exstrophy-epispadias complex who underwent gender reassignment, behavioral problems were comparable to those raised in their genetic , but gender-reassigned individuals reported higher rates of dissatisfaction with genital appearance and function. In female-raised 46, patients with penile agenesis or , psychosexual development leaned toward male patterns, including erotic interest in females and rejection of female role, leading to in most cases reviewed. Cognitive and psychopathology assessments in reassigned patients revealed no significant differences from non-reassigned peers, but persistent identity conflicts contributed to long-term challenges. Contemporary protocols have largely abandoned routine reassignment for 46,XY infants with or , favoring rearing based on these outcomes. Advances in phallic reconstruction have enabled better functional results in natal s, reducing the rationale for reassignment, while evidence of innate identity in genetically patients has shifted emphasis toward multidisciplinary support for genetic sex alignment. In classic exstrophy, where reassignment was historically rarer than in cloacal variants, retained assignment correlates with stronger psychosexual adjustment compared to reassigned cases, though both groups face elevated risks of and body image issues.

Prognosis and Long-Term Outcomes

Urinary Continence and Renal Function

In patients with classic bladder exstrophy undergoing modern staged repair, urinary continence is achieved in approximately 37% following successful and subsequent procedures such as or augmentation cystoplasty, though most require multiple interventions beyond initial . Only about 25% of patients attain daytime continence without additional after primary , with higher rates (up to 69%) following continent techniques including augmentation enterocystoplasty in 62% of cases. Factors influencing outcomes include preoperative , with volitional voiding preserved in roughly 60% of those achieving continence, though augmentation is necessary in up to 70% to support adequate and outlet resistance. Long-term continence rates improve with delayed procedures, as nearly half of initially incontinent patients with volitional voiding achieve dryness after age 10 without major additional , emphasizing the role of bladder growth and . However, persistent incontinence affects a significant minority, often necessitating lifelong clean intermittent catheterization in those diverted, with overall success tied to multidisciplinary follow-up rather than isolated surgical timing or use. Renal function is generally preserved in the majority of patients treated with staged reconstruction, with no evidence of broad negative impact on glomerular filtration rate (eGFR) over time despite early postoperative dips (e.g., mean eGFR of 68 mL/min/1.73 m² at 2 years versus normative 95.7). Chronic kidney disease (stage 3 or higher) occurs in 2-15% depending on closure success, with reclosure after failed primary repair associated with lower progression rates (3.9% versus 15.1%). Upper tract deterioration risks, including vesicoureteral reflux or hydronephrosis, are mitigated by vigilant surveillance and interventions like ureteral reimplantation, maintaining stable function in over 90% long-term when primary closure succeeds without complications.

Sexual Function and Fertility

In males with classic bladder exstrophy, is often compromised due to penile anomalies such as dorsal chordee, shortened penile length, and , which persist even after reconstructive surgeries like penile lengthening and . Satisfaction with penile appearance is reported in approximately 30% of adult males, while satisfaction with stands at around 35%, with common issues including and reduced ejaculatory force. Biologic paternity rates are low, ranging from 15% to 24% in surveyed cohorts, primarily attributable to impaired antegrade and rather than intrinsic testicular function. Fertility in males is further limited by the cumulative effects of multiple surgeries, which can damage patency and /seminal vesicle development, though assisted reproductive techniques like sperm retrieval have enabled fatherhood in select cases. Despite these challenges, many males report active sexual relationships, with up to 73% in stable partnerships, underscoring that while function is impaired, psychosocial can mitigate some impacts. In females with classic bladder exstrophy, is generally preserved post-reconstruction, with vaginal capacity often adequate for after procedures like , and rates comparable to age-matched controls in some cohorts. is less severely affected than in males, but pregnancies carry elevated risks including (up to 41%), preterm delivery (22% combined vaginal and cesarean), and maternal complications such as or issues. Successful term deliveries occur but are rare without cesarean section, with recommendations for multidisciplinary at centers to manage obstetric risks. Overall, while female patients demonstrate higher reproductive potential, long-term data emphasize the need for counseling on these heightened perinatal hazards.

Psychosocial Adjustment

Individuals with bladder exstrophy often encounter psychosocial challenges stemming from visible genital deformities, , and concerns over sexual function, which can affect , , and social interactions, particularly during . Studies indicate that adolescents report difficulties in disclosing their condition, experiencing , and navigating relationships, yet many employ effective strategies to pursue normalcy. In a of 22 adolescents aged 11-20 years, 50% met criteria for psychiatric diagnoses, with psychosocial dysfunction associated with urinary and , dissatisfaction with penile appearance (reported by 59%), and anxieties about future sexual partnerships. Despite these hurdles, and functioning in children and adolescents with bladder exstrophy-epispadias complex generally align with population norms, though emotional and behavioral problems may escalate in due to heightened concerns. tends to improve following continence-achieving surgeries in childhood but can decline during amid and peer pressures. differences influence outcomes, with females often reporting better perceptions of disadvantage compared to males, potentially linked to variances in and sexual function post-reconstruction. Long-term adjustment in adults appears largely positive, with literature highlighting despite ongoing physical challenges; however, persistent issues like incontinence and can undermine if unaddressed. Multidisciplinary care emphasizing screening, parental involvement, and transition support is recommended to mitigate risks, as predictors of better adjustment include early urinary continence and supportive family dynamics. Further longitudinal research is needed to track outcomes across the lifespan, particularly regarding psychosexual distress.

Historical Development

Early Observations and Attempts

The earliest recorded reference to bladder exstrophy appears on an Assyrian clay tablet dating to approximately 2000 BC, preserved in the British Museum, which describes a congenital anomaly consistent with the condition's characteristic exposure of the bladder mucosa through an abdominal wall defect. This ancient notation predates formal medical documentation by millennia, indicating recognition of the malformation in early civilizations, though without etiological insight or therapeutic intervention. The first detailed clinical description in Western medical literature emerged in 1597, when Marius von Grafenberg reported a case involving ectopia vesicae, noting the inverted bladder everted through a pubic symphysis defect, often accompanied by genital anomalies. Prior to the , management remained nonsurgical, relying on rudimentary measures such as of the exposed mucosa to reduce irritation and ulceration or application of escharotics to induce cicatricial contraction, which yielded inconsistent results and frequent complications like chronic and renal deterioration. Early surgical endeavors focused on rather than reconstruction; in 1852, in performed the first ureterosigmoidostomy on an exstrophy , implanting ureters into the rectosigmoid colon to bypass the defective , a procedure that became a standard albeit high-risk option for decades due to risks of ascending , , and malignancy. Attempts at primary bladder closure began sporadically in the mid-19th century but met with high failure rates owing to inadequate pelvic stabilization and tissue approximation techniques. Notable efforts included an 1853 procedure by , involving direct suturing of the to the , and a similar attempt by Pancoast shortly thereafter, both of which typically resulted in dehiscence, persistent incontinence, and progressive fibrosis. These interventions underscored the challenges of addressing the underlying infraumbilical wall deficiency and pubic diastasis without modern , antibiotics, or , often condemning patients to lifelong suppuration or diversion-related morbidity. By the late , ureterosigmoidostomy refinements, such as Maydl's tunneled implantation in 1892, offered marginal improvements in continence but perpetuated metabolic and oncologic hazards, highlighting the limitations of era-specific anatomical knowledge.

Modern Surgical Innovations

Modern staged repair of bladder exstrophy (MSRE), refined since the 1980s, involves initial neonatal bladder closure with pelvic osteotomy to stabilize the pubic diastasis, followed by repair at 6-12 months, and delayed bladder neck reconstruction with anti-incontinence procedures around age 4-5 years. This approach prioritizes early bladder cycling to promote capacity growth, achieving daytime continence in approximately 69-80% of patients long-term when combined with augmentation cystoplasty if needed, though nighttime continence often requires additional interventions like clean intermittent catheterization. Pelvic osteotomies, such as bilateral anterior innominate or combined anterior-posterior types, have become standard in closures after 72 hours of life to reduce dehiscence rates to under 10%. Complete primary repair of bladder exstrophy (CPRE), popularized in the 1990s and updated through the 2020s, aims for single-stage reconstruction in newborns, incorporating closure, , and penile disassembly-reassembly to address all components simultaneously. Proponents report higher initial continence rates (up to 85% in select series) without early surgery, but critics note increased risks of and penile complications, with reoperation rates exceeding 50% in some cohorts due to inadequate templates. Comparative studies from 2020-2025 indicate MSRE may yield superior capacity preservation, though CPRE reduces surgical episodes; choice depends on patient , with multidisciplinary consortia recommending individualized protocols. The radical soft-tissue , integrated into both MSRE and delayed repairs since the early 2000s, enhances penile length and approximation by extensive mobilization of corpora cavernosa without division, improving and function in up to 90% of cases per institutional series. Delayed primary closures, viable for infants up to 6 months, incorporate this technique to avoid risks of neonatal , with success rates comparable to immediate repair when osteotomies are used. Emerging adjuncts include bioregenerative scaffolds for bladder augmentation, with 2025 preclinical data showing 3D-printed biocompatible matrices supporting tissue integration and reducing fibrosis in animal models, though human trials remain pending. Overall, these innovations have lowered primary failure rates to 5-15% in high-volume centers, emphasizing preoperative imaging and postoperative .

References

  1. [1]
    Bladder exstrophy - Symptoms and causes - Mayo Clinic
    Jan 28, 2025 · Bladder exstrophy (EK-stroh-fee) is a rare condition present at birth. During pregnancy, the bladder of an unborn baby, also called a fetus, forms outside of ...
  2. [2]
    Bladder Exstrophy - StatPearls - NCBI Bookshelf - NIH
    Jun 3, 2023 · Bladder exstrophy is a rare congenital anomaly characterized by a spectrum of anomalies involving the ventral body wall, urinary tract, genitalia, bony pelvis, ...
  3. [3]
    Bladder exstrophy: navigating long-term outcomes - PMC - NIH
    Jun 26, 2025 · Bladder exstrophy (BE) is a rare congenital malformation of the lower genitourinary tract, abdominal wall, bony pelvis, genitalia, pelvic floor, ...
  4. [4]
    CONTEMPORARY EPIDEMIOLOGY OF BLADDER EXSTROPHY IN ...
    We identified 205 patients with exstrophy among 9,452,110 newborns. The overall weighted incidence of exstrophy was 2.15 per 100,000 live births. The male-to- ...<|control11|><|separator|>
  5. [5]
    Bladder Exstrophy-Epispadias-Cloacal Exstrophy Complex
    Aug 17, 2007 · The birth prevalence of classic bladder exstrophy has been estimated to be between 1 in 10,000 and 1 in 50,000 livebirths. Males are ...
  6. [6]
    Current management of classic bladder exstrophy in the modern era
    May 22, 2023 · Classic bladder exstrophy is a complex, multi-system congenital malformation affecting formation of the genitourinary system, pelvis, and abdominal wall.
  7. [7]
    Bladder exstrophy - Diagnosis and treatment - Mayo Clinic
    Jan 28, 2025 · The treatment for bladder exstrophy is surgery after birth. You may hear it called reconstructive surgery.Missing: definition | Show results with:definition
  8. [8]
    Contemporary issues relating to transitional care in bladder exstrophy
    Bladder exstrophy is a rare malformation characterized by an infra-umbilical abdominal wall defect, incomplete closure of the bladder with mucosa continuous ...
  9. [9]
    Modern Management of the Exstrophy-Epispadias Complex - PMC
    The exstrophy-epispadias complex is a rare spectrum of malformations affecting the genitourinary system, anterior abdominal wall, and pelvis.
  10. [10]
    The Exstrophy-epispadias complex
    Oct 30, 2009 · Prevalence at birth for the whole spectrum is reported at 1/10,000, ranging from 1/30,000 for CEB to 1/200,000 for EC, with an overall greater ...
  11. [11]
    Exstrophy-Epispadias Complex - PubMed
    Exstrophy-epispadias complex encompasses a spectrum of disorders with lower abdominal midline malformations, including epispadias, bladder exstrophy, and ...
  12. [12]
    Entry - BLADDER EXSTROPHY AND EPISPADIAS COMPLEX; BEEC
    They described BEEC as a spectrum of component malformations of variable severity, including epispadias as the mildest phenotype and classic bladder ...
  13. [13]
    The exstrophy-epispadias complex - PubMed
    Oct 30, 2009 · Exstrophy-epispadias complex (EEC) represents a spectrum of genitourinary malformations ranging in severity from epispadias (E) to classical bladder exstrophy ...
  14. [14]
    The Exstrophy-epispadias complex - PMC - PubMed Central - NIH
    Oct 30, 2009 · Exstrophy-epispadias complex (EEC) represents a spectrum of genitourinary malformations ranging in severity from epispadias (E) to classical bladder exstrophy ...
  15. [15]
    Exstrophy-epispadias complex - Orphanet
    In Europe, the combined birth incidence of EEC is reported at approximately 1/30,000, ranging from 1/46,000 for CEB to 1/317,000 for CE, with an overall greater ...
  16. [16]
    Exstrophy-Epispadias Complex Variants: A Hybrid Case - PMC - NIH
    Apr 7, 2021 · The term exstrophy-epispadias complex refers to a group of midline defects ranging from epispadias to cloacal exstrophy.
  17. [17]
    Variant Presentations of the Exstrophy-Epispadias Complex
    Aug 6, 2025 · Variant presentations included those with skin covered bladder exstrophy (BE), duplicate bladders, superior vesical fistula, and epispadias with ...<|separator|>
  18. [18]
    The Genomic Architecture of Bladder Exstrophy Epispadias Complex
    The bladder exstrophy–epispadias complex (BEEC) is an abdominal midline malformation comprising a spectrum of congenital genitourinary abnormalities.
  19. [19]
    Exstrophy Variants - Johns Hopkins Medicine
    Duplicate exstrophy: The pelvic bones may be abnormal as in classic bladder exstrophy, but a separate piece of the bladder is opened and flattened on the wall ...
  20. [20]
    The Genomic Architecture of Bladder Exstrophy Epispadias Complex
    Jul 28, 2021 · BEEC is further subdivided into “classic/typical” forms (E, CBE, and CE) and “atypical” forms (duplicated exstrophy, covered exstrophy, and ...
  21. [21]
    Genetics of Bladder-Exstrophy-Epispadias Complex (BEEC)
    Currently, only a few genes have been identified as being responsible for BEEC like phenotypes. One such example is the Ap2 gene, which has been suggested as ...
  22. [22]
    Analyzing the factors that contribute to the development of ...
    Embryological problems define the exstrophy-aspidistra complex, which resembles epimedium, classic bladder, cloacal exstrophy, and other diseases. Urogenital ...
  23. [23]
    Embryogenesis of bladder exstrophy: A new hypothesis - PMC - NIH
    [12] proposed a hypothesis that the abnormal persistence of the caudal position of the insertion of the body stalk on the embryo causes exstrophy bladder.
  24. [24]
    Pathogenesis of bladder exstrophy: A new hypothesis - PubMed
    Bladder exstrophy epispadias complex (BEEC) is a deformative disruption occurring after embryogenic phase and pubic diastasis, and is central to exstrophy ...
  25. [25]
    Clinical and molecular characterization of the bladder exstrophy ...
    Dec 6, 2004 · Normal embryological development of the bladder begins at 4–6 weeks of gestation, when the urogenital septum divides the cloaca into the ...<|separator|>
  26. [26]
    Bladder Exstrophy: An Epidemiologic Study From the International ...
    Oct 14, 2011 · The rare variant forms of BE include pseudoexstrophy, duplicate exstrophy, closed exstrophy, superior vesical fistula or fissure, inferior ...
  27. [27]
    Contemporary epidemiology of bladder exstrophy in the United States
    Results: We identified 205 patients with exstrophy among 9,452,110 newborns. The overall weighted incidence of exstrophy was 2.15 per 100,000 live births. The ...Missing: prevalence | Show results with:prevalence
  28. [28]
    A Multicountry Analysis of Prevalence and Mortality among ...
    Total prevalence of BE was 2.58 per 100000 births.. · Prevalence decreased from 2000 to 2014.. · The first-week mortality was 9.3%..Missing: incidence | Show results with:incidence
  29. [29]
    A Prevalence Estimation of Exstrophy and Epispadias in Germany ...
    Oct 26, 2021 · EUROCAT indicated the prevalence of bladder exstrophy and epispadias with 4.3 per 100,000 (1:23,300) live births in their last published report ...
  30. [30]
    Register Based Study of Bladder Exstrophy-Epispadias Complex
    Total prevalence of isolated cases of bladder exstrophy-epispadias complex was 3.52 per 100,000 births (95% CI 2.36-5.05) and live birth prevalence was 3.29 per ...
  31. [31]
    Register Based Study of Bladder Exstrophy-Epispadias Complex
    Total prevalence of isolated cases of bladder exstrophy-epispadias complex was 3.52 per 100,000 births (95% CI 2.36– 5.05) and live birth prevalence was 3.29 ...
  32. [32]
    CONTEMPORARY EPIDEMIOLOGY OF BLADDER EXSTROPHY IN ...
    Nonwhite race, uninsured status, high or low SES and Western geographic region are associated with lower exstrophy incidence. KEY WORDS: bladder exstrophy, ...
  33. [33]
    Classic bladder exstrophy - Orphanet
    Most patients have a genetically complex inheritance identified in a genome-wide association study where the recurrence risk was estimated at ~1%. In 1-3% of ...Missing: factors | Show results with:factors
  34. [34]
    Bladder Exstrophy-Epispadias-Cloacal Exstrophy Complex
    Dec 1, 2010 · The risk of recurrence of bladder exstrophy in a given family has been estimated to be approximately 1 in 100. Affected Organs. Pelvic Defects.
  35. [35]
    Bladder Exstrophy | Children's Hospital of Philadelphia
    Bladder exstrophy is a complex, rare disorder that occurs early on while a fetus is developing in the womb. As the bladder is developing the abdominal wall ...What is bladder exstrophy? · Prenatal care and delivery of... · Treatment · Follow up
  36. [36]
    Bladder Exstrophy - ISUOG
    Bladder exstrophy is often diagnosed by prenatal ultrasound, usually around 20 weeks of pregnancy at the time of the anatomy ultrasound. In fetuses with bladder ...
  37. [37]
    New sonographic finding for the prenatal diagnosis of bladder ...
    Apr 8, 2003 · The prenatal ultrasound findings of bladder exstrophy have been recognized as the presence of a solid bulging mass in the lower abdominal wall, ...Abstract · Introduction · Case report · Discussion
  38. [38]
    Prenatal Diagnosis of Bladder Exstrophy - Sage Journals
    Dec 30, 2013 · Common prenatal sonographic findings include an absent urinary bladder, normal amniotic fluid, and an inferior abdominal mass.
  39. [39]
  40. [40]
    Criteria for the prenatal diagnosis of classic bladder exstrophy
    The time of the fetal ultrasound varied from 14-36 weeks' gestation (mean 23). The diagnosis of bladder exstrophy was made before delivery in only three cases.
  41. [41]
    Register Based Study of Bladder Exstrophy-Epispadias Complex
    Accuracy of prenatal diagnosis was low, with 4 cases (10%) being detected prenatally by routine ultrasound (bladder exstrophy in 3, cloacal exstrophy in 1).<|separator|>
  42. [42]
    Prenatal diagnosis of bladder exstrophy by fetal MRI - PubMed
    Bladder exstrophy can be diagnosed by ultrasonography (US) evaluation of the fetus based on absence of bladder filling, low-set umbilicus, small genitalia and ...
  43. [43]
    Complex Genitourinary Abnormalities on Fetal MRI: Imaging ...
    Several MR features can aid in the prenatal diagnosis of bladder exstrophy. In bladder exstrophy, a normal bladder is not identified. Instead, an infraumbilical ...
  44. [44]
    A Single–Institutional Experience With Prenatal Diagnosis of ... - NIH
    In this study, the fMRI reached a 94.7% (18/19) sensitivity in prenatal CE identification. ... Prenatal diagnosis of bladder exstrophy and OEIS over 20 years.Missing: specificity | Show results with:specificity
  45. [45]
    Key anatomic findings on fetal ultrasound and MRI in the prenatal ...
    Jul 25, 2020 · Errors in diagnosis were due to a protuberant bladder plate extending beyond the plane of the abdominal wall with bowel loops posteriorly ...
  46. [46]
    Bladder Exstrophy: Causes, Symptoms & Treatment - Cleveland Clinic
    Aug 21, 2024 · But there's some evidence that genetics and environmental factors may play a role. Risk factors for bladder exstrophy include: Family ...
  47. [47]
    Recent Trends in the Management of Bladder Exstrophy - Frontiers
    Mar 28, 2019 · We review the literature of the last 15 years on the current concepts of bladder exstrophy repair with regard to the time of primary closure.Abstract · Main Surgical Concepts · Epispadias Repair · Need of Osteotomies
  48. [48]
    Bladder exstrophy: An overview of the surgical management - NIH
    The procedures available for the reconstruction are bladder closure, bladder neck repair, epispadias repair, ureteric reimplantation, bladder augmentation, ...Bladder Exstrophy: An... · Materials And Methods · Bladder Neck RepairMissing: review | Show results with:review
  49. [49]
    Perioperative management of classic bladder exstrophy - PMC - NIH
    This article will review the spectrum of bladder exstrophy anomalies, the surgical repair, and the perioperative interdisciplinary management.
  50. [50]
    Classic bladder exstrophy: orthopaedic surgical considerations
    Surgical options include a multiyear staged approach and the single-stage complete repair for exstrophy. The goals of urologic surgery include closure of the ...
  51. [51]
    Bladder Exstrophy | Johns Hopkins Medicine
    The risk of having a child with exstrophy is one in 70, if the parents have exstrophy. Major genetic studies are currently underway at Johns Hopkins involving ...Missing: factors | Show results with:factors
  52. [52]
    Ensuring our exstrophy-epispadias complex patients and families ...
    Jul 6, 2023 · Individuals with bladder exstrophy-epispadias complex (EEC) need long-term integrated medical/surgical and psychosocial care.
  53. [53]
    Somatic function, mental health and psychosocial ... - PubMed
    Purpose: We report the long-term somatic outcome, mental health and psychosocial adjustment in adolescents with bladder exstrophy and epispadias.
  54. [54]
    Gender Assignment for Newborns With 46XY Cloacal Exstrophy
    Most pediatric urologists favor male gender assignment for 46XY cloacal exstrophy, which is a significant increase in 6 years.Missing: karyotype | Show results with:karyotype
  55. [55]
    Discordant sexual identity in some genetic males with cloacal ...
    Conclusions: Routine neonatal assignment of genetic males to female sex because of severe phallic inadequacy can result in unpredictable sexual identification.
  56. [56]
    Psychosexual development in genetic males assigned female
    Psychosexual development, including gender identity, in genetic and hormonal male neonates seems to be influenced heavily by prenatal androgen exposure.
  57. [57]
    Long-term adjustment issues in patients with exstrophy - PubMed
    ... gender reassignment versus no reassignment. Conclusions: Children with ... Bladder Exstrophy / psychology*; Child; Child, Preschool; Female; Humans; Male ...
  58. [58]
    Gender identity outcome in female-raised 46,XY persons with penile ...
    This article presents a literature review of gender outcome in three pertinent conditions (penile agenesis, cloacal exstrophy of the bladder, and penile ...
  59. [59]
    Psychopathology, psychosocial, gender and cognitive outcomes in ...
    Gender reassigned participants with cloacal exstrophy were compared with nonassigned participants with cloacal exstrophy. ... Bladder Exstrophy / genetics ...
  60. [60]
    Updates on the Care of Cloacal Exstrophy - PubMed
    May 2, 2024 · Increased attention is given to gender identity and the implications of reconstructive decisions. Long-term sequelae of cloacal exstrophy ...
  61. [61]
    Long-term psychosexual adjustment of adults born with classic ...
    Apr 22, 2024 · When it came to gender, females significantly performed worse than males regarding psychosexual identity ... Keywords: Bladder exstrophy; ...
  62. [62]
    Urinary Continence Outcomes in Classic Bladder Exstrophy - PubMed
    Results: Overall 432 patients underwent successful bladder closure (primary 71.5%, repeat 28.5%) and a urinary continence procedure. At last followup 162 (37%) ...
  63. [63]
    Urinary Continence Outcomes in Classic Bladder Exstrophy
    Jan 1, 2020 · Most patients with classic bladder exstrophy require multiple reconstructive procedures to achieve continence. Only about 25% of patients are expected to void ...Patient Demographics · Continence Outcomes · Discussion
  64. [64]
    Long‐term urinary outcomes in classic bladder exstrophy
    A total of 69% of patients underwent continent urinary diversion, 61.9% underwent augmentation enterocystoplasty (AEC), and 7.1% underwent bladder neck closure.
  65. [65]
    Preoperative Bladder Capacity Predicts Social Continence following ...
    Dec 22, 2022 · Young-Dees-Leadbetter bladder neck reconstruction yielded rates of 33% for full continence and 67% for social continence and volitional voiding.
  66. [66]
    Continence and classic bladder exstrophy treated with staged repair
    Continence can be achieved in most patients with classic bladder exstrophy. However, augmentation was required in 30 of 43 patients (70%).
  67. [67]
    Development of Late Continence in Bladder Exstrophy and ...
    Conclusion. Almost half of the incontinent CBE and epispadias patients with volitional voiding achieved continence after the age of 10 without major surgery.<|separator|>
  68. [68]
    A critical appraisal of continence in bladder exstrophy - PubMed
    Of those achieving continence, 59% will do so with zero or one additional operation. Sex and osteotomy status were not associated with continence outcomes, ...<|control11|><|separator|>
  69. [69]
    Preservation of renal function in the modern staged repair of classic ...
    The staged reconstruction of exstrophy does not appear to negatively impact renal function in most patients.
  70. [70]
    Preservation of renal function in the modern staged repair of classic ...
    Jul 11, 2012 · However, the mean eGFR in exstrophy patients was significantly lower than norms between 8 days (44.8 vs 65.8, p < 0.0001) and 2 years of life ( ...
  71. [71]
    End-Stage and Chronic Kidney Disease in Classic Bladder Exstrophy
    May 20, 2024 · Previous studies looking at renal outcomes in CBE have not adjusted for differential follow-up time. Kanobolo et al reported that 2% of 36 ...
  72. [72]
    PD55-07 LONG-TERM RENAL OUTCOMES IN ADULT CLASSIC ...
    May 1, 2024 · Patients who required reclosure after failed primary closure were significantly less likely to progress to CKD stage 3 (3.9% vs. 15.1%, p=0.011) ...Missing: preservation | Show results with:preservation
  73. [73]
    Kidney function outcomes in patients after complete primary repair of ...
    We aim to evaluate the risk of upper urinary tract deterioration or chronic kidney disease after the complete primary repair of exstrophy (CPRE).
  74. [74]
    Sexual function and fertility issues in cases of exstrophy epispadias ...
    Most of the female patients have normal fertility while male patients have significantly low fertility. Most of the male and female patients with EEC have ...Missing: classical dysfunction
  75. [75]
    Long term outcomes in classic bladder exstrophy - The adult picture
    Jul 3, 2023 · 73% were in stable relationships, however only 30% were satisfied with their penile appearance and 35% with their sexual function status. This ...
  76. [76]
    Bladder exstrophy in adulthood: A narrative review of transitional ...
    EEC occurs in 1 in 10,000 live births and classically presents as bladder exstrophy (BE), with an estimated male to female ratio of 2.4:1–6:1 [1]. BE is a ...
  77. [77]
    PD15-08 THE EXSTROPHY EXPERIENCE - Journal of Urology
    Sep 1, 2021 · Fifteen (23.8%) of the 63 patients who responded to male fertility questions reported successful biologic paternity. Eight (53.3%) patients used ...Missing: classical dysfunction
  78. [78]
    Update on Sexual and Reproductive Function in Bladder Exstrophy
    Mar 9, 2023 · Adults with a history of bladder exstrophy can have satisfying sexual function and successfully conceive children.Missing: peer- reviewed
  79. [79]
    Sexual Function and Fertility of Women with Classic Bladder ...
    Conclusions: The sexuality and fertility of female patients with exstrophy after continent urinary diversion appears to be comparable with those in previously ...Missing: peer- | Show results with:peer-
  80. [80]
    Patient-reported outcomes in adult females with bladder exstrophy
    Jun 21, 2020 · Outcomes of 100 pregnancies included miscarriage/abortion (41.0%), preterm vaginal (3.0%), preterm cesarean section (19.0%), term vaginal (2.0%) ...
  81. [81]
    Reproductive outcomes in women with classic bladder exstrophy
    Mar 23, 2012 · Fertility is impaired in women with bladder exstrophy. Pregnancy is high risk both for the mother and baby.
  82. [82]
    Reproductive outcomes in women with classic bladder exstrophy
    Conclusion. Fertility is impaired in women with bladder exstrophy. Pregnancy is high risk both for the mother and baby. Delivery should be at a tertiary ...
  83. [83]
    The psychosocial impact of bladder exstrophy in adolescence
    The psychosocial impact of bladder exstrophy in adolescence. J Adolesc Health ... bladder exstrophy. Results: Participants described difficulties ...
  84. [84]
    Mental health, psychosocial functioning, and health-related quality ...
    Sep 21, 2024 · Mental health, psychosocial functioning, and health-related quality of life of children and adolescents with bladder exstrophy, cloacal ...
  85. [85]
    An investigation into the psychological impact of bladder exstrophy
    The literature suggests that psychosocial outcome for adults with bladder exstrophy is positive. Several studies report psychological difficulties associated ...
  86. [86]
    Historical trends in the management of bladder exstrophy
    The history of bladder exstrophy dates back to 2000 B.C., there being a reference to this congenital anomaly on an Assyrian tablet preserved in the Britis.
  87. [87]
    Bladder exstrophy-epispadias-cloacal exstrophy complex
    Jun 1, 2024 · Bladder exstrophy-epispadias-cloacal exstrophy complex (BEEC) is a spectrum of congenital urologic anomalies that involve the bladder, urethra, ...
  88. [88]
    Bladder Exstrophy - an overview | ScienceDirect Topics
    BLADDER EXSTROPHY. Definite historical descriptions of bladder exstrophy date back to at least 1597 with von Grafenberg's description of this congenital defect.
  89. [89]
    Exstrophy and Epispadias—Modern Staged Approach
    Apr 24, 2020 · Until the middle of the 19th century, bladder exstrophy was treated primarily nonsurgically. Early forms of repair focused on abdominal wall ...<|control11|><|separator|>
  90. [90]
    [Development of treatment for extrophy-epispadias in Germany]
    The first ureterosigmoidostomy was done in an exstrophy patient by Simon in Heidelberg in 1852, after which Maydl described a new technique based on ...Missing: early | Show results with:early
  91. [91]
    COMPLETE REPAIR OF BLADDER EXSTROPHY - Journal of Urology
    The idea of an anal sphincter controlled bladder substitute as a treatment option for bladder exstrophy came to reality in the nineteenth century. The ...
  92. [92]
    Bladder Exstrophy | Operative Pediatric Surgery, 2e - AccessSurgery
    A few scattered attempts at bladder closure were made in the middle of the 1800s. One attempt by Richard was made in 1853, and another was performed by Pancoast ...
  93. [93]
    Bladder and Cloacal Exstrophy - Clinical Gate
    Feb 27, 2015 · The goals have expanded since the first operations were attempted in the 19th century. These objectives address the primary pathophysiology of ...
  94. [94]
  95. [95]
    Long‐term urinary outcomes in classic bladder exstrophy: results of ...
    Feb 26, 2025 · Most patients were treated using the modern staged repair exstrophy technique (88.1%) with pelvic osteotomy (95.2%). A total of 69% of patients ...
  96. [96]
    Modern staged repair of bladder exstrophy: a contemporary series
    The purpose of this study was to evaluate long-term outcomes in a select group of patients in whom modern staged repair (MSRE) was undertaken.Missing: management team approach
  97. [97]
    Multi-Institutional Bladder Exstrophy Consortium After 8 Years
    Jul 1, 2024 · An initial report of a novel Multi-Institutional Bladder Exstrophy Consortium: a collaboration focused on primary surgery and subsequent care.
  98. [98]
  99. [99]
    Engineering the Future of Bladder Repair: Can Biocompatible 3D ...
    Sep 10, 2025 · Conclusion: This 3D-printed scaffold demonstrates promising biocompatibility, mechanical durability, and integration in bladder repair.Missing: 2020-2025 | Show results with:2020-2025
  100. [100]
    Bladder Exstrophy - African Journal of Paediatric Surgery
    Surgical management of bladder exstrophy is extremely complex and requires multiple interventions. The success of initial bladder and posterior urethra closure ...Modern Staged Repair... · Abstract · Discussion